News and Updates by the Food and Drugs Administration (FDA)
In a landmark effort to intensify the battle against tuberculosis (TB), healthcare executives from corporate and private hospitals throughout Uttar Pradesh gathered in Ghaziabad. Approximately 50 prominent corporate and private hospitals, including various clinicians, participated in the event. This meeting […]
Corporate Healthcare Leaders Form Alliance with AHPI to Eradicate TB in Uttar Pradesh Read More »
For over 40 years, Orbis India, a non-profit dedicated to preventing and treating blindness, emphasizes that a promising future starts with healthy vision, prompting an appeal for proactive eye care in the young. Undiagnosed childhood vision problems can severely affect
Orbis India Advocates for Early Eye Care in Children to Ensure a Bright Future Read More »
Inventurus Knowledge Solutions Limited has successfully secured Rs. 1,120.18 crore from 61 prominent anchor investors, with an offer price of Rs. 1,329/- per share, including a share premium of Rs. 1,328/- per share. A total of 8,428,730 equity shares were
Inventurus Knowledge Solutions Secures Rs. 1,120.18 crore from 61 Key Investors Read More »
FemPulse revealed today that it has secured IDE (Investigational Device Exemption) approval from the FDA for its treatment targeting overactive bladder (OAB). This paves the way for the initiation of the EVANESCE II pivotal clinical trial focusing on female patients
FemPulse Gains FDA IDE Approval for Overactive Bladder Neuromodulation Device Read More »
Bausch + Lomb has revealed that its subsidiary has completed the acquisition of Elios Vision, a pioneer in minimally invasive glaucoma surgery (MIGS) techniques. The Elios technique utilizes an excimer laser during cataract surgeries to manage glaucoma without requiring any
Bausch + Lomb Completes Acquisition of Glaucoma Surgery Innovator Elios Vision Read More »
Karl Storz U.S. has rolled out Pathway.AI, a novel tool in collaboration with Artisight, within the United States. Artisight’s smart hospital platform supports the AI tool that is crafted to detect and address changes in the operating room (OR) status.
Karl Storz Debuts AI Innovation to Boost Operating Room Performance Read More »
Theradaptive recently disclosed that it has obtained FDA authorization to expand its study on OsteoAdapt SP. This enlarged trial incorporates three types of spinal fusion indications and will increase the number of investigational locations in the U.S. threefold. Earlier this
Theradaptive Gains FDA Consent for Broadened OsteoAdapt SP Clinical Study Read More »
Augmedics has recently appointed Paul Ziegler as its new CEO and president. In light of this leadership change, Gwen Watanabe is set to shift from her interim CEO role to serve as vice chair on the board. Watanabe served in
Paul Ziegler Appointed as the New CEO at Augmedics Read More »
Capstan Medical has successfully secured $110 million through a highly sought-after Series C funding round, as announced by the company today. Specializing in structural heart surgical robots, Capstan Medical plans to use this influx of funds to prepare for its
Cipher Pharmaceuticals Inc., a company specializing in pharmaceuticals and boasting a wide range of commercialized as well as early to advanced stage products, has disclosed that its collaborator, Moberg Pharma AB, has released a statement indicating that MOB-015, a treatment